RxDoctor Payments Data

Eureka Armstrong

Physician Assistant · Chester, PANPI 1649469545

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 451 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Gilead at 43.3% of the total. 2025 is the largest year on record at $2,728, 2.0 times the $1,343 reported in 2021. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,870in general payments, 2019–2025

Across 451 payments — averaging $24.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$5K
  • Viiv Healthcare Company$3K
  • Merck$921
  • AbbVie$490
  • Theratechnologies Inc.$459
  • Johnson & Johnson$258
  • plus $561 from 11 others

What the payments were for

  • Food & beverage$10,870100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,870 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania →

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala132$507,463
TriumeqAbacavir/Dolutegravir/Lamivudi41$155,633
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf28$116,586
OdefseyEmtricitab/Rilpiviri/Tenof Ala30$100,974
GenvoyaElviteg/Cob/Emtri/Tenof Alafen12$47,007
DescovyEmtricitabine/Tenofov Alafenam21$46,204
PrezcobixDarunavir/Cobicistat13$32,809
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr41$21,897
TrulicityDulaglutide16$14,340
Breo ElliptaFluticasone/Vilanterol36$14,042
OzempicSemaglutide13$12,390
Albuterol Sulfate HfaAlbuterol Sulfate49$2,061
Ventolin HfaAlbuterol Sulfate24$1,345
Efavirenz-Emtric-Tenofov DisopEfavirenz/Emtricit/Tenofovr Df11$874
ValacyclovirValacyclovir Hcl28$697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Descovy$4,706$600,674165 claims
Viiv Healthcare CompanyTriumeq$3,477$155,63341 claims
Johnson & JohnsonPrezcobix$258$32,80913 claims
Lilly USA, LLCTrulicity, Olanzapine$45$14,53032 claims
Novo NordiskOzempic$36$12,39013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Chester

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →